Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xulin
- Development stage
- Preclinical
- Lead developer
- AVN Ayurveda Formulations
- Administration
- Oral
01
Overview
**Xulin** is a proprietary oral Ayurvedic multi-herb formulation developed and manufactured by AVN Ayurveda Formulations. It is supplied as tablets and is positioned for support of metabolic balance and healthy blood sugar levels; the supplied pipeline context identifies diabetes as its intended therapeutic area and reports clinical-trial development. Public product information lists Gudmar, Vijaysar, Amalaki, Haridra, Daruharidra, Jambu, Meshashringi, Guduchi, Triphala, and Shilajit as formulation ingredients. Its molecular targets and clinically established mechanism of action have not been publicly specified. ([webstore.avnarogya.in](https://webstore.avnarogya.in/products/XulinTablet/506002000018680015))
- Brand names
- Xulin
Beyond the preview
Go deeper on Xulin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xulin.